Marketing-authorisation holder Β· Canada
Pro Doc Limitee
776 medicines in 1 country, as authorisation holder.
Loading your pageβ¦
Marketing-authorisation holder Β· Canada
776 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1β25 of 776
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALENDRONATE-1010 mg Β· Tablet | Alendronic acid | Canada | Authorised | |
| ALENDRONATE-4040 mg Β· Tablet | Alendronic acid | Canada | Authorised | |
| ALENDRONATE-55 mg Β· Tablet | Alendronic acid | Canada | Authorised | |
| ALENDRONATE-7070 mg Β· Tablet | Alendronic acid | Canada | Marketed | 2008 |
| ALLOPURINOL-100100 mg Β· Tablet | Allopurinol | Canada | Marketed | 1982 |
| ALLOPURINOL-200200 mg Β· Tablet | Allopurinol | Canada | Marketed | 1995 |
| ALLOPURINOL-300300 mg Β· Tablet | Allopurinol | Canada | Marketed | 1982 |
| ALMOTRIPTAN12.5 mg Β· Tablet | Almotriptan | Canada | Marketed | 2014 |
| AMLODIPINE10 mg Β· Tablet | Amlodipine | Canada | Marketed | 2009 |
| AMLODIPINE2.5 mg Β· Tablet | Amlodipine | Canada | Marketed | 2009 |
| AMLODIPINE5 mg Β· Tablet | Amlodipine | Canada | Marketed | 2009 |
| ARIPIPRAZOLE15 mg Β· Tablet | Aripiprazole | Canada | Marketed | 2019 |
| ARIPIPRAZOLE2 mg Β· Tablet | Aripiprazole | Canada | Marketed | 2019 |
| ARIPIPRAZOLE20 mg Β· Tablet | Aripiprazole | Canada | Marketed | 2019 |
| ARIPIPRAZOLE30 mg Β· Tablet | Aripiprazole | Canada | Marketed | 2019 |
| ARIPIPRAZOLE5 mg Β· Tablet | Aripiprazole | Canada | Marketed | 2019 |
| ARIPIPRAZOLE10 mg Β· Tablet | Aripiprazole | Canada | Marketed | 2019 |
| CANDESARTAN16 mg Β· Tablet | Candesartan cilexetil | Canada | Marketed | 2012 |
| CANDESARTAN32 mg Β· Tablet | Candesartan cilexetil | Canada | Marketed | 2014 |
| CANDESARTAN8 mg Β· Tablet | Candesartan cilexetil | Canada | Marketed | 2012 |
| CANDESARTAN-HCTZ16.0 mg + 12.5 mg Β· Tablet | Candesartan cilexetil, Hydrochlorothiazide | Canada | Marketed | 2012 |
| CARVEDILOL25.0 mg Β· Tablet | Carvedilol | Canada | Marketed | 2009 |
| CARVEDILOL3.125 mg Β· Tablet | Carvedilol | Canada | Marketed | 2009 |
| CARVEDILOL6.25 mg Β· Tablet | Carvedilol | Canada | Marketed | 2009 |
| CARVEDILOL12.5 mg Β· Tablet | Carvedilol | Canada | Marketed | 2009 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 776 | 346 | 430 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.